TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses

Vaccines are a powerful medical intervention for preventing epidemic diseases. Efficient inactivated or protein vaccines typically rely on an effective adjuvant to elicit an immune response and boost vaccine activity. In this study, we investigated the adjuvant activities of combinations of Toll-lik...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jing-Xing, Tseng, Jen-Chih, Tien, Chih-Feng, Lee, Chia-Yin, Liu, Yi-Ling, Lin, Jhe-Jhih, Tsai, Pei-Ju, Liao, Hung-Chun, Liu, Shih-Jen, Su, Yu-Wen, Hsu, Li-Chung, Chen, Jen-Kun, Huang, Ming-Hsi, Yu, Guann-Yi, Chuang, Tsung-Hsien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266083/
https://www.ncbi.nlm.nih.gov/pubmed/37324951
http://dx.doi.org/10.7150/ijbs.81210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266083/
https://www.ncbi.nlm.nih.gov/pubmed/37324951
http://dx.doi.org/10.7150/ijbs.81210

Ejemplares similares